Sandy Mahatme
President, COO and CFO @ Resilience
Cambridge, United States
Sandy Mahatme is a startup investor at Resilience in Cambridge. Sandesh "Sandy" Mahatme is a multi-faceted executive leader who currently serves as the Chief Business Officer, Chief Financial Officer, and Executive Vice President of Sarepta Therapeutics, a leading biotechnology company dedicated to helping patients overcome rare diseases. Through his work at Sarepta, Sandesh has expanded thecompany's financial backing exponentially, closing over $2.5 billion in business development and investment deals. Prior to stepping into these roles. Sandy gained vital experience as Corporate Treasurer, Head of Tax, Senior Vice President of Finance, and Corporate Strategic Development and Initiatives at several other companies. Previously, he also served as Senior Counsel for Pfizer. To glean further insight into Sandesh Mahatme's career, as well as his passion for his current work, be sure to visit his website.
Last updated:
For AI agents: llms.txt
About Resilience
Resilience is a technology-driven biomanufacturing company committed to expanding access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company is creating a sustainable network of advanced, end-to-end manufacturing solutions to ensure that today's and tomorrow's treatments can beproduced rapidly, safely, and at scale. By continuously innovating in biopharmaceutical manufacturing and development, Resilience enables its partners to focus on breakthrough discoveries that enhance patient outcomes while safeguarding biopharmaceutical supply chains against future disruptions.
Resilience Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bill Reid
CISO and VP, Security and Privacy
|
|||
Eytan Abraham
VP, Head of Cell Therapy Franchise
|
|||
Rahul Singhvi
Co-Founder & CEO
|
|||
Ross Leimberg
Senior Director of Business Development
|
|||
|
Sandy Mahatme
President, COO and CFO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
